Author

Laura O’Reilly

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:software / tool· 1

Frequent Co-Authors

George CarnelliD· 2 shared Jonathan Luke HeeneyiD· 2 shared Phil PalmeriD· 2 shared Sneha VishwanathiD· 2 shared Andrew C. Y. ChaniD· 1 shared Charlotte L. GeorgeiD· 1 shared Chloe Qingzhou HuangiD· 1 shared Ernest T. AguinamiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

George CarnellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyEmerging Microbes & InfectionsPeer-reviewedJun 6, 2025

Digitally immune optimised haemagglutinin with nanocage plug-and-display elicits broadly neutralising pan-H5 influenza subtype vaccine responses

Chloe Qingzhou Huang, Rory A. Hills, George Carnell…·Jonathan Luke Heeney

This paper develops a vaccine candidate using DIOSvax-H5inter nanocages that elicits cross-clade neutralising antibodies and T cell responses against diverse H5 influenza strains.

8 citationstop 4%

mouseproteomics

𝕏 PostBluesky

BioinformaticsbioRxivPreprintApr 14, 2025

Covering All Bases: A Computational Method to Design Broad-spectrum T-cell-inducing Vaccines Applied to Betacoronaviruses

Phil Palmer, Sofiya Fedosyuk, Srivatsan Parthasarathy…·Sneha Vishwanath

This paper introduces Spectravax, a computational method to design broad-spectrum T-cell-inducing vaccines, and demonstrates its effectiveness against Betacoronaviruses.

DOI 10.1101/2025.04.14.648815

humanproteomics

𝕏 PostBluesky